請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/77176完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 方啟泰(Chi-Tai Fang) | |
| dc.contributor.author | Yu-Chen Cheng | en |
| dc.contributor.author | 鄭妤貞 | zh_TW |
| dc.date.accessioned | 2021-07-10T21:49:30Z | - |
| dc.date.available | 2021-07-10T21:49:30Z | - |
| dc.date.copyright | 2019-08-28 | |
| dc.date.issued | 2019 | |
| dc.date.submitted | 2019-08-19 | |
| dc.identifier.citation | 1. 衛生福利部國民健康署. 中華民國104年癌症登記報告. 2017.
2. Haggar FA, Boushey RP. Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors. Clinics in Colon and Rectal Surgery 2009;22:191-7. 3. Gagnière J, Raisch J, Veziant J, et al. Gut microbiota imbalance and colorectal cancer. World Journal of Gastroenterology : WJG 2016;22:501-18. 4. Goodman B, Gardner H. The microbiome and cancer. The Journal of pathology 2018;244:667-76. 5. Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. PloS one 2011;6:e20447. 6. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS one 2011;6:e16393. 7. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nature reviews Microbiology 2012;10:575-82. 8. Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (New York, NY) 2012;338:120-3. 9. Nougayrede JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (New York, NY) 2006;313:848-51. 10. Johnson JR, Johnston B, Kuskowski MA, Nougayrede JP, Oswald E. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. Journal of clinical microbiology 2008;46:3906-11. 11. Buc E, Dubois D, Sauvanet P, et al. High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer. PloS one 2013;8:e56964. 12. Chen YT, Lai YC, Tan MC, et al. Prevalence and characteristics of pks genotoxin gene cluster-positive clinical Klebsiella pneumoniae isolates in Taiwan. Scientific reports 2017;7:43120. 13. Lai YC, Lin AC, Chiang MK, et al. Genotoxic Klebsiella pneumoniae in Taiwan. PloS one 2014;9:e96292. 14. Swidsinski A, Khilkin M, Kerjaschki D, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998;115:281-6. 15. Lin Y-T, Siu LK, Lin J-C, et al. Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy Chinese and overseas Chinese adults in Asian countries. BMC microbiology 2012;12:13-. 16. Liu KL, Sun HY, Fang CT. Liver Abscess and Metastatic Endophthalmitis Secondary to Klebsiella pneumoniae K1. The American journal of gastroenterology 2017;112:13. 17. Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 2013;4:107-18. 18. Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. The Lancet Infectious diseases 2012;12:881-7. 19. Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26:1434-8. 20. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45:284-93. 21. Follador R, Heinz E, Wyres KL, et al. The diversity of Klebsiella pneumoniae surface polysaccharides. Microbial genomics 2016;2:e000073. 22. Paczosa MK, Mecsas J. Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiology and molecular biology reviews : MMBR 2016;80:629-61. 23. Huang WK, Chang JW, See LC, et al. Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11-year follow-up study. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2012;14:e794-801. 24. Jeong SW, Jang JY, Lee TH, et al. Cryptogenic pyogenic liver abscess as the herald of colon cancer. Journal of gastroenterology and hepatology 2012;27:248-55. 25. Kao WY, Hwang CY, Chang YT, et al. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Alimentary pharmacology & therapeutics 2012;36:467-76. 26. Lai HC, Lin HC. Cryptogenic pyogenic liver abscess as a sign of colorectal cancer: a population-based 5-year follow-up study. Liver international : official journal of the International Association for the Study of the Liver 2010;30:1387-93. 27. Qu K, Liu C, Wang ZX, et al. Pyogenic liver abscesses associated with nonmetastatic colorectal cancers: an increasing problem in Eastern Asia. World Journal of Gastroenterology : WJG 2012;18:2948-55. 28. Brisse S, Passet V, Haugaard AB, et al. wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. Journal of clinical microbiology 2013;51:4073-8. 29. Talbot D, Duchesne T, Brisson J, Vandal N. Variance estimation and confidence intervals for the standardized mortality ratio with application to the assessment of a cancer screening program. Statistics in medicine 2011;30:3024-37. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/77176 | - |
| dc.description.abstract | 背景:在臺灣地區大腸直腸癌發生、死亡人數,每年呈快速增加的趨勢,根據台灣癌症登記中心的統計資料,在1979年到2015年近30年間大腸直腸癌的發生率增加了大約5倍,目前居所有癌症發生率及死亡率的第一位及第三位1。已有許多研究指出腸道微生物菌叢所製造的毒素可能是大腸直腸癌的危險因子之一,本研究欲探討的pks基因最早是在腸道外致病性的大腸桿菌中被發現,pks基因負責調控基因毒素Colibactin的合成,先前在細胞以及動物實驗證實帶有pks基因的克雷伯氏肺炎桿菌會造成DNA雙股螺旋斷裂,進而誘發大腸直腸癌,顯示帶有pks基因的克雷伯氏肺炎桿菌可能是大腸直腸癌的危險因子之一。另外也有流行病學研究發現,克雷伯氏肺炎桿菌肝膿瘍患者後續罹患大腸直腸癌的風險比起非克雷伯氏肺炎桿菌肝膿瘍患者來得高,顯示克雷伯氏肺炎桿菌與大腸直腸癌具有相關性,但目前流行病學的研究無法直接驗證帶有pks基因之克雷伯氏肺炎桿菌與大腸直腸癌的相關性。
研究目的:初步探討感染帶有pks基因的克雷伯氏肺炎桿菌是否會增加罹患大腸直腸癌的風險。 方法:本研究以常規收集臨床檢體之克雷伯氏肺炎桿菌菌株資料庫作為研究族群,首先挑選177株分離自肝膿瘍病人之克雷伯氏肺炎桿菌菌株,並利用PCR偵測pks基因上之clbA, clbB, clbN, clbQ基因座,確認菌株是否帶有pks基因,了解pks基因在高毒性克雷伯氏肺炎桿菌菌株中之分布狀況。另外藉由勾稽台大醫院癌症登記資料庫以及衛生福利部死因統計檔,確認病患之罹癌及存活情況,建立克雷伯氏肺炎桿菌菌株cohort,並計算cohort之大腸直腸癌標準化發生率比(standardized incidence rate ratio, SIR),以及以pks盛行率隨機抽樣模擬計算帶有pks基因之克雷伯氏肺炎桿菌之大腸直腸癌標準化發生率比,初步分析感染帶有pks基因的克雷伯氏肺炎桿菌是否會增加罹患大腸直腸癌的風險。另外透過病例對照研究設計,了解pks基因在大腸直腸癌患者以及對照組間的分布是否有差異。 結果:分析177株肝膿瘍病患所分離出之克雷伯氏肺炎桿菌菌株,pks基因之盛行率為57.6%,高於一般臨床檢體所分離出來的克雷伯氏肺炎桿菌菌株之盛行率,其中pks基因主要分布於高毒性莢膜血清型K1 (78.8%)、K2 (41.7%)以及K20 (57.1%)之菌株中。全部克雷伯氏肺炎桿菌cohort之大腸直腸癌標準化發生率為1.3 (95%信賴區間 0.96- 1.69)。進一步區分,pks-positive克雷伯氏肺炎桿菌cohort大腸直腸癌標準化發生率比為2.0 (95%信賴區間1.19- 2.92),達統計顯著;而pks-negative克雷伯氏肺炎桿菌cohort大腸直腸癌標準化發生率則為1.1 (95%信賴區間 0.71- 1.52),未達統計顯著。病例對照研究發現大腸直腸癌患者所分離出之克雷伯氏肺炎桿菌株較一般來源族群分離出之克雷伯氏肺炎桿菌菌株有顯著較高的比例帶有pks基因 (30% vs. 16.7%, p<0.001)。 結論:本研究為第一個探討帶有pks基因的克雷伯氏肺炎桿菌與大腸直腸癌相關性之流行病學研究,我們的分析結果顯示克雷伯氏肺炎桿菌肝膿瘍患者中分離出之高毒性克雷伯氏肺炎桿菌菌株有將近60%帶有pks基因。標準化發生率比以及病例對照研究結果都支持pks-positive克雷伯氏肺炎桿菌與大腸直腸癌的相關性,因此未來值得繼續投入於這個重要的公共衛生議題。 | zh_TW |
| dc.description.abstract | Background: Colorectal cancer (CRC) is the most common cancer and the third leading cause of cancer-related death in Taiwan. The risk factors for CRC include genetic factors, life style factors, and microbial etiology such as colibactin-producing intestinal bacteria. Recently, studies found that Klebsiella pneumoniae with pks colibactin gene may induce carcinogenesis in vivo and in vitro. The higher rate of CRC in patients with K. pneumoniae pyogenic liver abscess (PLA) than in those with non-K. pneumoniae PLA also supported that K. pneumoniae might be the microbial etiology of CRC. Therefore, we used a case-control study and standardized incidence rate ratio (SIR) calculation to preliminary investigate the link between pks-positive K. pneumoniae and colorectal cancer.
Aims: To preliminary investigate the link between pks-positive K. pneumoniae and colorectal cancer. Material: Our K. pneumoniae cohort is comprised of 8,675 K. pneumoniae strains from patients at National Taiwan University Hospital and Yunlin branch from 2004 to 2018. The presence of pks colibactin genes among K. pneumoniae strains were determined by PCR with primer for clbA, clbB, clbN, and clbQ on the pks gene cluster. We will determine whether and when the cohort subjects were diagnosis to had colorectal cancer by crosslinking Taiwan cancer registry. We will use the colorectal cancer incidence of age-, sex- and year-matched Taiwan general population as the external comparison group to calculate the standardized incidence rate ratio (SIR). The SIR is defined as the ratio between numbers of observed cases O and numbers of expected cases E. E is calculated by multiplying the number of person-years by the colorectal cancer incidence rates for each 5-year age groups, and 5-year calendar periods of the cohort members, the 95% confidence intervals (CIs) are based on the Poisson distribution. We also conduct a case-control study to determine whether the distribution of pks gene in case and control group different. Results: The prevalence of pks gene was 57.6% in the K. pneumoniae strains isolated from pyogenic liver abscess patients, and predominately in K1 (78.8%), K2 (41.7%) and K20 (57.1%) hypervirulence capsular type. The CRC standardized incidence rate ratio (SIR) of the whole KP cohort was 1.3 (95% CI 0.96- 1.69). The result of pks-positive SIR was 2.0 (95%CI 1.19- 2.92) and pks-negative SIR was 1.1 (95%CI 0.71- 1.52). In case-control study, the results show that the rate of pks gene was significantly higher in the K. pneumoniae strains isolated from CRC patients and the pks rate in case and control were 30% vs. 16.7% (p<0.001). Conclusions: Our results of SIR and pilot case-control study preliminarily support our hypothesis that the carriage of pks gene cluster may serve as a molecular basis underlying the epidemiological link between K. pneumoniae and CRC. | en |
| dc.description.provenance | Made available in DSpace on 2021-07-10T21:49:30Z (GMT). No. of bitstreams: 1 ntu-108-R06849023-1.pdf: 1168235 bytes, checksum: 693d0e89aab9cca544c8367484bfd4f3 (MD5) Previous issue date: 2019 | en |
| dc.description.tableofcontents | 誌謝 i
摘要 ii Abstract v 目錄 vii 表目錄 ix 圖目錄 x 緒論 1 背景 1 高毒性克雷伯氏肺炎桿菌與大腸直腸癌之相關性 1 高毒性克雷伯氏肺炎桿菌與pks基因之相關性 2 知識缺口 (Gap in Knowledge) 2 研究目標 3 材料與方法 4 建立克雷伯氏肺炎桿菌菌株之世代資料 (cohort) 4 克雷伯氏肺炎桿菌菌株來源 4 勾稽台大醫院癌症登記小組之癌症登記資料 4 勾稽衛生福利部衛生福利資料科學中心的衛生福利資料檔死因統計檔 5 建立偵測克雷伯氏肺炎桿菌中pks基因的方法 5 高毒性克雷伯氏肺炎桿菌中pks基因的分布 6 研究樣本 6 K莢膜血清基因型偵測 6 計算年齡標準化發生率比 (Standardized Incidence Ratios, SIR) 6 以隨機抽樣方式模擬計算克雷伯氏肺炎桿菌菌株之世代資料pks-positive以及pks-negative樣本之年齡標準化發生率比 7 病例對照研究設計 7 將國家衛生研究院之研究結果作為對照組進行檢定 8 結果 9 克雷伯氏肺炎桿菌菌株之世代資料 (cohort) 9 高毒性克雷伯氏肺炎桿菌中pks基因的分布 10 年齡標準化發生率比 (Standardized Incidence Ratios, SIR) 10 模擬計算克雷伯氏肺炎桿菌菌株之世代資料庫pks-positive以及pks-negative樣本之年齡標準化發生率比 10 病例對照研究 11 將國家衛生研究院之研究結果作為對照組進行檢定 11 討論 13 參考文獻 16 | |
| dc.language.iso | zh-TW | |
| dc.subject | 基因毒素 | zh_TW |
| dc.subject | 病例對照研究 | zh_TW |
| dc.subject | 大腸直腸癌 | zh_TW |
| dc.subject | 克雷伯氏肺炎桿菌 | zh_TW |
| dc.subject | colibaction | en |
| dc.subject | case-control study | en |
| dc.subject | Klebsiella pneumoniae | en |
| dc.subject | genotoxin | en |
| dc.subject | colorectal cancer | en |
| dc.title | 基因毒性克雷伯氏肺炎桿菌與大腸直腸癌之相關性:前驅性研究 | zh_TW |
| dc.title | Genotoxic Klebsiella pneumoniae and Colorectal Cancer:
A Pilot Study | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 107-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李文宗(Wen-Chung Lee),范怡琴(Yi-Chin Fan) | |
| dc.subject.keyword | 克雷伯氏肺炎桿菌,基因毒素,大腸直腸癌,病例對照研究, | zh_TW |
| dc.subject.keyword | Klebsiella pneumoniae,colorectal cancer,colibaction,genotoxin,case-control study, | en |
| dc.relation.page | 33 | |
| dc.identifier.doi | 10.6342/NTU201904027 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2019-08-20 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| 顯示於系所單位: | 流行病學與預防醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-108-R06849023-1.pdf 未授權公開取用 | 1.14 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
